|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
(+ 0 more)
153 a.a.
|
 |
|
|
|
|
|
|
|
(+ 0 more)
89 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Caspase-8 specificity probed at subsite s4: crystal structur caspase-8-z-devd-cho
|
|
Structure:
|
 |
Caspase-8 alpha chain. Chain: a, c, e, g, i, k. Engineered: yes. Caspase-8 beta chain. Chain: b, d, f, h, j, l. Engineered: yes. (Phq)devd. Chain: q, r, s, t, u, v. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Other_details: chemically synthesized
|
|
Biol. unit:
|
 |
Hexamer (from
)
|
|
Resolution:
|
 |
|
2.90Å
|
R-factor:
|
0.241
|
R-free:
|
0.289
|
|
|
Authors:
|
 |
H.Blanchard,M.Donepudi,M.Tschopp,L.Kodandapani,J.C.Wu,M.G.Gr
|
Key ref:
|
 |
H.Blanchard
et al.
(2000).
Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex.
J Mol Biol,
302,
9.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
10-Jul-00
|
Release date:
|
10-Jul-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C, D, E, F, G, H, I, J, K, L:
E.C.3.4.22.61
- Caspase-8.
|
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
apoptosis
|
2 terms
|
 |
|
Biochemical function
|
cysteine-type peptidase activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
302:9
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex.
|
|
H.Blanchard,
M.Donepudi,
M.Tschopp,
L.Kodandapani,
J.C.Wu,
M.G.Grütter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Caspase-8 is an initiator enzyme in the Fas-mediated pathway of which the
downstream executioner caspase-3 is a physiological target. Caspases are
cysteine proteases that are specific for substrates with an aspartic acid
residue at the P(1) position and have an optimal recognition motif that
incorporates four amino acid residues N-terminal to the cleavage site. Caspase-8
has been classified as a group III caspase member because it shows a preference
for a small hydrophobic residue at the P(4) substrate position. We report the
X-ray crystallographic structure of caspase-8 in complex with
benzyloxycarbonyl-Asp-Glu-Val-Asp-aldehyde (Z-DEVD), a specific group II caspase
inhibitor. The structure shows that the inhibitor interacts favourably with the
enzyme in subsite S(4). Kinetic data reveal that Z-DEVD (K(i) 2 nM) is an almost
equally potent inhibitor of caspase-8 as the specific group III inhibitor
Boc-IETD-aldehyde (K(i) 1 nM). In view of this finding, the original
classification of caspases into three specificity groups needs to be modified,
at least for caspase-8, which tolerates small hydrophobic residues as well as
the acidic residue Asp in subsite S(4). We propose that the subsite S(3) must be
considered as an important specificity-determining factor.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. A diagram of Z-DEVD hydrogen bond interactions
with caspase-8. Hydrogen bonds are shown as broken lines. This
diagram was produced in ChemDraw.
|
 |
Figure 3.
Figure 3. Stereoview of the superposition of
caspase-8-Z-DEVD onto caspase-8-Z-EVD highlighting the hydrogen
bond interaction at subsite S[3]. Superposition was done using
the C^a atoms of the conserved subsite S[1] active-site residues
Cys285, His237 and Arg341, and was extended for all atoms in a
(p18/p12)[2] subunit using LSQMAN [Kleywegt and Jones 1994].
Shown in green is the caspase-8-Z-EVD structure and its hydrogen
bond interactions [Blanchard et al 1999]. Caspase-8-Z-DEVD is
shown in gold. Both inhibitors are shown in atom colours as ball
and stick representations. The structures are depicted as
main-chain ball and stick representations with all atoms shown
for residues belonging to Loop-1; the hydrogen bond is depicted
as dotted spheres and the Figure was produced in Setor [Evans
1993].
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2000,
302,
9-0)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Pop,
A.Oberst,
M.Drag,
B.J.Van Raam,
S.J.Riedl,
D.R.Green,
and
G.S.Salvesen
(2011).
FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity.
|
| |
Biochem J, 433,
447-457.
|
 |
|
|
|
|
 |
N.Keller,
M.G.Grütter,
and
O.Zerbe
(2010).
Studies of the molecular mechanism of caspase-8 activation by solution NMR.
|
| |
Cell Death Differ, 17,
710-718.
|
 |
|
|
|
|
 |
B.Fang,
G.Fu,
J.Agniswamy,
R.W.Harrison,
and
I.T.Weber
(2009).
Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling.
|
| |
Apoptosis, 14,
741-752.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Keller,
J.Mares,
O.Zerbe,
and
M.G.Grütter
(2009).
Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation.
|
| |
Structure, 17,
438-448.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Yoshimori,
J.Sakai,
S.Sunaga,
T.Kobayashi,
S.Takahashi,
N.Okita,
R.Takasawa,
and
S.Tanuma
(2007).
Structural and functional definition of the specificity of a novel caspase-3 inhibitor, Ac-DNLD-CHO.
|
| |
BMC Pharmacol, 7,
8.
|
 |
|
|
|
|
 |
J.Agniswamy,
B.Fang,
and
I.T.Weber
(2007).
Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.
|
| |
FEBS J, 274,
4752-4765.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.J.Henzing,
H.Dodson,
J.M.Reid,
S.H.Kaufmann,
R.L.Baxter,
and
W.C.Earnshaw
(2006).
Synthesis of novel caspase inhibitors for characterization of the active caspase proteome in vitro and in vivo.
|
| |
J Med Chem, 49,
7636-7645.
|
 |
|
|
|
|
 |
C.D.Austin,
D.A.Lawrence,
A.A.Peden,
E.E.Varfolomeev,
K.Totpal,
A.M.De Mazière,
J.Klumperman,
D.Arnott,
V.Pham,
R.H.Scheller,
and
A.Ashkenazi
(2006).
Death-receptor activation halts clathrin-dependent endocytosis.
|
| |
Proc Natl Acad Sci U S A, 103,
10283-10288.
|
 |
|
|
|
|
 |
P.K.Ho,
and
C.J.Hawkins
(2005).
Mammalian initiator apoptotic caspases.
|
| |
FEBS J, 272,
5436-5453.
|
 |
|
|
|
|
 |
C.M.Forsyth,
D.Lemongello,
D.J.LaCount,
P.D.Friesen,
and
A.J.Fisher
(2004).
Crystal structure of an invertebrate caspase.
|
| |
J Biol Chem, 279,
7001-7008.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Schweizer,
C.Briand,
and
M.G.Grutter
(2003).
Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway.
|
| |
J Biol Chem, 278,
42441-42447.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.W.Chang,
Z.Xing,
V.L.Capacio,
M.E.Peter,
and
X.Yang
(2003).
Interdimer processing mechanism of procaspase-8 activation.
|
| |
EMBO J, 22,
4132-4142.
|
 |
|
|
|
|
 |
M.Bando,
M.Hasegawa,
Y.Tsuboi,
Y.Miyake,
M.Shiina,
M.Ito,
H.Handa,
K.Nagai,
and
T.Kataoka
(2003).
The mycotoxin penicillic acid inhibits Fas ligand-induced apoptosis by blocking self-processing of caspase-8 in death-inducing signaling complex.
|
| |
J Biol Chem, 278,
5786-5793.
|
 |
|
|
|
|
 |
M.Donepudi,
A.Mac Sweeney,
C.Briand,
and
M.G.Grütter
(2003).
Insights into the regulatory mechanism for caspase-8 activation.
|
| |
Mol Cell, 11,
543-549.
|
 |
|
|
|
|
 |
A.Ueki,
Y.Isozaki,
A.Tomokuni,
T.Hatayama,
H.Ueki,
M.Kusaka,
M.Shiwa,
H.Arikuni,
T.Takeshita,
and
K.Morimoto
(2002).
Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals.
|
| |
Clin Exp Immunol, 129,
556-561.
|
 |
|
|
|
|
 |
E.L.Meyer,
L.C.Gahring,
and
S.W.Rogers
(2002).
Nicotine preconditioning antagonizes activity-dependent caspase proteolysis of a glutamate receptor.
|
| |
J Biol Chem, 277,
10869-10875.
|
 |
|
|
|
|
 |
J.Salgado,
A.J.García-Sáez,
G.Malet,
I.Mingarro,
and
E.Pérez-Payá
(2002).
Peptides in apoptosis research.
|
| |
J Pept Sci, 8,
543-560.
|
 |
|
|
|
|
 |
O.Micheau,
M.Thome,
P.Schneider,
N.Holler,
J.Tschopp,
D.W.Nicholson,
C.Briand,
and
M.G.Grütter
(2002).
The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex.
|
| |
J Biol Chem, 277,
45162-45171.
|
 |
|
|
|
|
 |
H.Loetscher,
O.Niederhauser,
J.Kemp,
and
R.Gill
(2001).
Is caspase-3 inhibition a valid therapeutic strategy in cerebral ischemia?
|
| |
Drug Discov Today, 6,
671-680.
|
 |
|
|
|
|
 |
M.Buck,
V.Poli,
T.Hunter,
and
M.Chojkier
(2001).
C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival.
|
| |
Mol Cell, 8,
807-816.
|
 |
|
|
|
|
 |
Y.Huang,
Y.C.Park,
R.L.Rich,
D.Segal,
D.G.Myszka,
and
H.Wu
(2001).
Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain.
|
| |
Cell, 104,
781-790.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.G.Grütter
(2000).
Caspases: key players in programmed cell death.
|
| |
Curr Opin Struct Biol, 10,
649-655.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|